Total Funding
80
76
Total FundingSeed raised
Growth Score
-9 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
19749
Ladder Bio is a therapeutics company that develops synthetic, ladder-shaped compounds engineered for high specificity and stability.
- Eric Heil: CEOPast Role: Health Quality Partners, Senior Vice President of Global Growth and Opportunity
- Past Role: Temple University, Assistant Professor
About the Company
Ladder Bio is a therapeutics company that develops synthetic, ladder-shaped compounds engineered for high specificity and stability. The platform combines rational molecular design with computational discovery to create therapeutics with the potency of biologics but the drug-like stability, oral bioavailability, and cell permeability of small
molecules. Ladder Bio also sees applications for its Spiroligomer chemistry in diagnostics, where the high-affinity binding and synthetic stability can replace more variable biologics.
